Aradco Pars

AradCo. Pars Company was established in 2021 with the aim of domestic production of high-tech pharmaceutical products. The primary objective would revolve around representing well-reputed big pharmaceuticals in Iran. The main areas of activities, in the first step would be establishing of a line of quality under-licensed generic medicines, which surprisingly country faces occasional shortages. In latter phases, the spectrum of activities will expand biotechnological area, such as blood factors, followed by a range of specialty supplements. Regarding the production site, the company’s strategy is contract production and optimized use of the current capacities of the country, which was created by the private and public sectors, such as the Vice Presidency for Scientific and Technological Affairs. In addition, according to our facilities, the company has made attempts to construct production lines based on cGMP and daily production standards in Europe, in this regard, the designs of production lines (Conceptual, Basic and Detailed Design) on the land purchased by the AradCo. is also in progress.